The US Food and Drug Administration (FDA) has granted accelerated approval for Mirati Therapeutics’ Krazati (adagrasib) for treatment of mutated locally advanced or metastatic non-small cell lung cancer in adults. This accelerated…
Breathe Test to Detect Lung Cancer, Scientists Suggests
Lung cancer is one of the most common types of cancers all around the world and has the highest death rate. The reason behind high death rate is that it is often…
How to Cope Up With Fear of Recurrence Of Lung Cancer
When the treatment for lung cancer begins, the patients eagerly wait for the completion. But, one of the most common issues being faced by lung cancer survivors is the fear of recurrence…
Study Shows Alarming Rise in Lung Cancer Cases among non-smokers, Youth and Women
A study has been conducted by team of doctors from Medanta Gurugram, India that suggests possible increase in non-smokers and women lung cancer cases. Dr. Arvind Kumar and his team studied 304…
Lung Cancer Awareness Month Theme is “A Breath of Prevention”
Lung cancer is one of the most deadly diseases that affects both men and women all around the world. It is the second common type of cancer. It is responsible for taking…
US FDA Approves Imfinzi and Imjudo with Chemotherapy for Lung Cancer
AstraZeneca’s Imfinzi in combination with Imjudo plus platinum-based chemotherapy has been approved for treatment of patients with Stage IV non-small cell lung cancer (NSCLC). The approval has been made by the Food…
Role of Artificial Intelligence in Detecting Lung Cancer
The deadly disease of lung cancer is the leading cause of malignancy-related mortality worldwide owing to its diagnosis at a later stage. About 75% of those with lung cancer die within five…
Study Shows Circadian Rhythm Disruptions Linked To Enhanced Lung Cancer Growth
According to a new paper co-authored by University of Rochester Wilmot Cancer Institute investigator and led by the Scripps Research Institute in California, a vital molecular link is between growth of lung…